Crescent Biopharma Inc. (CBIO)
NASDAQ: CBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CBIO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $501.11M
- EPS (TTM)
- -$7.63
- Dividend yield
- None
- Ex-dividend date
- Jan 13, 2023
- 52-week range
- 8.72 – 27.41
- Day range
- 13.27 – 14.18
- Volume / Avg
- 1.05M / 383.95K
- Beta
- —
- Shares outstanding
- 37.14M
- Next earnings
- Nov 5, 2026
52-week range
CBIO stock today
Shares of Crescent Biopharma (CBIO) finished lower on Oct 7 at $13.49, a drop of 0.59% or $0.08 per share, versus the S&P 500's 0.22% decline. Volume was 2.7x the average at 1.05M shares, a sign of unusually heavy trading. Shares are 50.8% below their 52-week high of $27.41, set on Apr 22, 2026 and 54.7% above the 52-week low of $8.72, in the middle of the past year's range.
CBIO is up 13.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 19.5%. Crescent Biopharma has posted a net loss over the last twelve months (EPS of -$7.63), so its P/E ratio is not meaningful. Crescent Biopharma's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Crescent Biopharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2014
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.72
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $24.00
- Ex-dividend date
- Jan 13, 2023
Crescent Biopharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PBYIPuma Biotechnology Inc | 9.81 | +3.26% | $506.39M | vs CBIO |
| ACRSAclaris Therapeutics Inc. | 3.40 | -8.11% | $500.48M | vs CBIO |
| EOLSEvolus Inc. | 7.74 | +4.88% | $511.23M | vs CBIO |
| DRUGBright Minds Biosciences Inc. | 52.00 | +7.77% | $512.93M | vs CBIO |
| ALTAltimmune Inc. | 2.66 | -0.37% | $517.42M | vs CBIO |
| NGNENeurogene Inc. | 25.87 | +1.65% | $517.69M | vs CBIO |
| MPLTMapLight Therapeutics Inc. | 9.36 | -3.41% | $520.19M | vs CBIO |
| OCSOculis Holding AG | 8.50 | -2.52% | $523.50M | vs CBIO |
Indexes, lists and sector
Appears in lists
Crescent Biopharma stock FAQ
What is Crescent Biopharma's stock price today?
CBIO last traded at $13.49 as of Oct 7, 4:00 PM EDT, down 0.59% on the day. Prices are delayed at least 15 minutes.
Does Crescent Biopharma pay a dividend?
Yes. Crescent Biopharma pays $0.00 per share annually. The most recent dividend of $24.00 had an ex-dividend date of Jan 13, 2023.
When is Crescent Biopharma's next earnings date?
Crescent Biopharma is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.72.
Has CBIO ever split its stock?
Yes. The most recent CBIO stock split was a 1-for-100 split on Jun 16, 2025.
What is the CBIO 52-week high?
The 52-week high for CBIO is $27.41 and the 52-week low is $8.72. The stock is currently 50.8% below its high.